How can hepatitis C/HIV co-infections be treated in resource-poor countries?


In developing countries many patients affected by hepatitis C, which can cause severe liver disease and death, are also HIV positive. Treatment is complicated due to high treatment costs, the absence of the high-tech equipment needed to make a diagnosis and the lack of clinical expertise. ITM researchers are running a pilot treatment project in Cambodia to help shape a replicable model of care, as they did in the early 2000s for antiretroviral treatment against HIV. Data will also be used to develop simple clinical decision-making tools that can help bypass the need for the high-tech equipment and costly tests.

Hepatitis C treatment for HIV patients in resource-poor countries: is a public health approach possible?

Principal investigator


SOFI Budget


Key facts